Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Mayur, Parihar"'
Autor:
Pritam Singha Roy, Manash Pratim Gogoi, Debjani Ghosh, Nandana Das, Parag Das, Deepak Mishra, Mayur Parihar, Asish Rath, Sushant S. Vinarkar, Niharendu Ghara
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 9, Iss 4, Pp S58- (2024)
Externí odkaz:
https://doaj.org/article/cbea0a1df1ae43c0bf95a5d289cc90b0
Autor:
Vivek Sulekha Radhakrishnan, Padmaja Lokireddy, Mayur Parihar, Prashanth Srirangapattana Prakash, Hari Menon
Publikováno v:
Cancer Reports, Vol 5, Iss 7, Pp n/a-n/a (2022)
Abstract Background Mantle cell lymphoma (MCL) is a rare type of mature B‐cell lymphoid malignancy with the pathologic hallmark of translocation t(11;14) (q13, q32), which leads to an overexpression of Cyclin D1 (CCND1). The disease is also charact
Externí odkaz:
https://doaj.org/article/782ce941546343a48adfc8e299b91360
Autor:
Simon Bomken, Amir Enshaei, Edward C. Schwalbe, Aneta Mikulasova, Yunfeng Dai, Masood Zaka, Kent T.M. Fung, Matthew Bashton, Huezin Lim, Lisa Jones, Nefeli Karataraki, Emily Winterman, Cody Ashby, Andishe Attarbaschi, Yves Bertrand, Jutta Bradtke, Barbara Buldini, G.A. Amos Burke, Giovanni Cazzaniga, Gudrun Gohring, Hesta A. de Groot-Kruseman, Claudia Haferlach, Luca Lo Nigro, Mayur Parihar, Adriana Plesa, Emma Seaford, Edwin Sonneveld, Sabine Strehl, Vincent H.J. van der Velden, Vikki Rand, Stephen P. Hunger, Christine J. Harrison, Chris M. Bacon, Frederik W. van Delft, Mignon L. Loh, John Moppett, Josef Vormoor, Brian A. Walker, Anthony V. Moorman, Lisa J. Russell
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukemia (BCP-ALL) carries an immunoglobulin- MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma/leukemia and use of individualized tr
Externí odkaz:
https://doaj.org/article/7ac03037b4cc476bb5a3d391aea80fe8
Autor:
Rimpa Basu Achari, Santam Chakraborty, Love Goyal, Saheli Saha, Paromita Roy, Lateef Zameer, Deepak Mishra, Mayur Parihar, Anirban Das, Aditi Chandra, Bivas Biswas, Indranil Mallick, Moses A. Arunsingh, Sanjoy Chatterjee, Tapesh Bhattacharyya
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEThere are limited reports of quality metrics in glioblastoma. We audited our adherence to quality indicators as proposed in the PRIME Quality Improvement study.METHODSThis is a retrospective audit of patients treated between 2017 and 2020. Aft
Externí odkaz:
https://doaj.org/article/546fd860dc054c6490434025496e63df
Autor:
Vivek S. Radhakrishnan, Rajat Bajaj, Vasundhara Raina, Jeevan Kumar, Saurabh J. Bhave, Reghu K. Sukumaran Nair, Arijit Nag, Indu Arun, Lateef Zameer, Debdeep Dey, Neeraj Arora, Mayur Parihar, Jayanta Das, Rimpa B. Achari, Deepak K. Mishra, Mammen Chandy, Reena Nair
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
IntroductionDespite high cure rates with standard treatment, 30% patients with Hodgkin lymphoma develop relapsed or refractory (R/R) disease. Salvage therapy followed by autologous hematopoietic cell transplantation (HCT) is considered standard of ca
Externí odkaz:
https://doaj.org/article/dae1e4f52afa48cfae5a870c4b097c72
Autor:
Simon Bomken, Amir Enshaei, Edward C. Schwalbe, Aneta Mikulasova, Yunfeng Dai, Masood Zaka, Kent T.M. Fung, Matthew Bashton, Huezin Lim, Lisa Jones, Nefeli Karataraki, Emily Winterman, Cody Ashby, Andishe Attarbaschi, Yves Bertrand, Jutta Bradtke, Barbara Buldini, G.A. Amos Burke, Giovanni Cazzaniga, Gudrun Gohring, Hesta A. De Groot-Kruseman, Claudia Haferlach, Luca Lo Nigro, Mayur Parihar, Adriana Plesa, Emma Seaford, Edwin Sonneveld, Sabine Strehl, Vincent H.J. Van der Velden, Vikki Rand, Stephen P. Hunger, Christine J. Harrison, Chris M. Bacon, Frederik W. Van Delft, Mignon L. Loh, John Moppett, Josef Vormoor, Brian A. Walker, Anthony V. Moorman, Lisa J. Russell
Publikováno v:
Haematologica, 108(3), 717-731. Ferrata Storti Foundation
Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukemia (BCP-ALL) carries an immunoglobulin- MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma/leukemia and use of individualized tr
Autor:
Ravikiran N Pawar, Sambhunath Banerjee, Subhajit Bramha, Shekhar Krishnan, Arpita Bhattacharya, Vaskar Saha, Anupam Chakrapani, Saurabh Bhave, Mammen Chandy, Reena Nair, Mayur Parihar, Neeraj Arora, D K Mishra
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 60, Iss 1, Pp 43-49 (2017)
Introduction: Mixed-phenotype acute leukemias (MPALs) are a heterogeneous group of rare leukemias constituting approximately 2%–5% of all leukemias, in which assigning a single lineage of origin is not possible. They are diagnosed by either the pre
Externí odkaz:
https://doaj.org/article/cd11d9912752401cb44cacf06ed96f1c
SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE
Autor:
Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019017-e2019017 (2019)
Introduction: For diagnosis, sub-categorization and follow up of Acute Leukemia (AL), phenotypic analysis using flow cytometry is mandatory. Material and methods: We retrospectively analyzed immunophenotypic data along with cytogenetics/molecular
Externí odkaz:
https://doaj.org/article/552377e637ac4f8e93dd340c22bfec78
Publikováno v:
Indian Journal of Medical and Paediatric Oncology.
Plasma cell dyscrasias are a heterogeneous group of neoplasms characterized by abnormal proliferation of plasma cells with or without over production of monoclonal immunoglobulins. Chromosomal abnormalities are acquired either early in the course of
Publikováno v:
Indian Journal of Medical and Paediatric Oncology.
Modern therapeutic protocols in acute leukemias risk stratify disease based on genetic characterization of the neoplastic cells and their response to treatment. Genetic characterization is routinely performed by cytogenetic testing of leukemic cells